open166 vistasGlobal

Investigator-Initiated Studies (IIS) Program

UCB's Investigator-Initiated Studies (IIS) program supports independent clinical and non-clinical research initiated by investigators to enhance medical and scientific knowledge. Funding and/or investigational drugs may be provided upon internal review and approval. Applications are accepted on a rolling basis via the online submission portal.

Quién puede solicitar

Investigators from nonpharmaceutical institutions (academic, associations, or individual physicians/academics) who have the required qualifications, experience, and commitment to conduct and manage the proposed study.

Fuentes

Enlaces utilizados por la IA para recopilar información sobre esta subvención.

Sitio web del organizador Ver fuente

Regístrese para obtener coincidencias automáticas con subvenciones como esta.

Comenzar gratis

Criterios de elegibilidad

IISs are clinical studies and non-clinical studies which have been solely conceived, initiated and conducted by a nonpharmaceutical institution (ie, academic), associations (medical professionals or patients) or investigator/physician/academic.
The investigator must have the required qualifications and experience to conduct and manage the study being proposed.
The study should have scientific merit and align with UCB's areas of interest (immunology, neurology, rare diseases).
The study must be well designed with a robust proposal that can meet ethical and regulatory requirements.
The investigator must be motivated and committed to ensure the study meets its aim and is completed according to agreed timelines.

Investigator-Initiated Studies (IIS) Program

Fuentes

Similar grants